NO904069L - Fremgangsmaate for fremstilling av nye alkanofenoner. - Google Patents

Fremgangsmaate for fremstilling av nye alkanofenoner.

Info

Publication number
NO904069L
NO904069L NO90904069A NO904069A NO904069L NO 904069 L NO904069 L NO 904069L NO 90904069 A NO90904069 A NO 90904069A NO 904069 A NO904069 A NO 904069A NO 904069 L NO904069 L NO 904069L
Authority
NO
Norway
Prior art keywords
alkanophenons
procedure
preparation
new
new alkanophenons
Prior art date
Application number
NO90904069A
Other languages
English (en)
Other versions
NO904069D0 (no
Inventor
Andreas Von Sprecher
Andreas Beck
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO904069D0 publication Critical patent/NO904069D0/no
Publication of NO904069L publication Critical patent/NO904069L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
NO90904069A 1989-09-19 1990-09-18 Fremgangsmaate for fremstilling av nye alkanofenoner. NO904069L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH340189 1989-09-19

Publications (2)

Publication Number Publication Date
NO904069D0 NO904069D0 (no) 1990-09-18
NO904069L true NO904069L (no) 1991-03-20

Family

ID=4255188

Family Applications (1)

Application Number Title Priority Date Filing Date
NO90904069A NO904069L (no) 1989-09-19 1990-09-18 Fremgangsmaate for fremstilling av nye alkanofenoner.

Country Status (16)

Country Link
US (1) US5145868A (no)
EP (1) EP0419410A3 (no)
JP (1) JPH03112987A (no)
KR (1) KR910006269A (no)
AU (1) AU630231B2 (no)
CA (1) CA2025470A1 (no)
DD (1) DD295846A5 (no)
FI (1) FI904570A0 (no)
HU (1) HU207067B (no)
IE (1) IE903375A1 (no)
IL (1) IL95678A0 (no)
MX (1) MX22430A (no)
NO (1) NO904069L (no)
NZ (1) NZ235335A (no)
PT (1) PT95336A (no)
ZA (1) ZA907422B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1681287A1 (en) 2000-07-04 2006-07-19 Ube Industries, Ltd. Benzoxazole compounds, process for producing the same, and herbicides
EP1429746B1 (en) 2001-09-28 2008-08-13 McNEIL-PPC, INC. Dosage forms having an inner core and outer shell
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
US7323192B2 (en) * 2001-09-28 2008-01-29 Mcneil-Ppc, Inc. Immediate release tablet
US7122143B2 (en) 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
WO2004058786A1 (en) * 2002-12-31 2004-07-15 Council Of Scientific And Industrial Research Process for the synthesis of 2-deoxy-d-glucose
US8673352B2 (en) 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0079637B1 (en) * 1981-11-12 1987-01-28 FISONS plc Anti-srs-a carboxylic acid derivatives, processes for their production, and pharmaceutical formulation containing them
DE3469169D1 (en) * 1983-04-21 1988-03-10 Merck Frosst Canada Inc Leukotriene antagonists, their production and use and compositions containing them
US4609744A (en) * 1983-04-21 1986-09-02 Merck Frosst Canada Inc. 4-oxo-benzopyran carboxylic acids
GB8320943D0 (en) * 1983-08-03 1983-09-07 Lilly Industries Ltd Organic compounds
EP0147217A3 (en) * 1983-12-27 1986-08-13 Merck Frosst Canada Inc. Leukotriene antagonists
US4761425A (en) * 1983-12-27 1988-08-02 Merck Frosst Canada, Inc. Leukotriene antagonists
DE3582527D1 (en) * 1984-06-28 1991-05-23 Ciba Geigy Ag Aliphatische thioether.
CA1309557C (en) * 1985-06-18 1992-10-27 Robert N. Young Leukotriene antagonists
FI864901A (fi) * 1985-12-06 1987-06-07 Ciba Geigy Ag Hydroxitioetrar.
US4785004A (en) * 1985-12-23 1988-11-15 Ciba-Geigy Corporation Aromatic thioethers
JPH0753725B2 (ja) * 1987-10-08 1995-06-07 富山化学工業株式会社 4h―1―ベンゾピラン―4―オン誘導体およびその塩、それらの製造法並びにそれらを含有する抗炎症剤
IL89713A0 (en) * 1988-03-29 1989-09-28 Ciba Geigy Ag Novel alkanophenones

Also Published As

Publication number Publication date
ZA907422B (en) 1991-05-29
AU6260690A (en) 1991-03-28
NZ235335A (en) 1992-12-23
CA2025470A1 (en) 1991-03-20
MX22430A (es) 1993-12-01
NO904069D0 (no) 1990-09-18
EP0419410A2 (de) 1991-03-27
US5145868A (en) 1992-09-08
HU207067B (en) 1993-03-01
KR910006269A (ko) 1991-04-29
EP0419410A3 (en) 1991-08-14
DD295846A5 (de) 1991-11-14
IE903375A1 (en) 1991-04-10
JPH03112987A (ja) 1991-05-14
AU630231B2 (en) 1992-10-22
FI904570A0 (fi) 1990-09-17
HUT54677A (en) 1991-03-28
IL95678A0 (en) 1991-06-30
PT95336A (pt) 1991-05-22

Similar Documents

Publication Publication Date Title
NO873091L (no) Fremgangsmaate for fremstilling av nye benzimidazolderivater.
NO902003D0 (no) Fremgangsmaate for fremstilling av n-heteroaryl-4-quinolinaminer.
NO904059D0 (no) Fremgangsmaate for fremstilling av nye substituerte isokinoliner.
NO901554L (no) Fremgangsmaate for fremstilling av dinatrium-cefodizim.
NO902776D0 (no) Fremgangsmaate for fremstilling av nye acetylcholinesterase-inhibitorer.
NO904285L (no) Fremgangsmaate for fremstilling av substituerte karboksytetrahydroisokinoliner.
NO901813D0 (no) Fremgangsmaate for fremstilling av nye tieno-triazolo-diazepin-derivater.
NO913391D0 (no) Fremgangsmaate for fremstilling av nye hetrazepinoide syreamider.
NO900074L (no) Fremgangsmaate for fremstilling av nye tetralinderivater.
NO904069D0 (no) Fremgangsmaate for fremstilling av nye alkanofenoner.
NO892977D0 (no) Fremgangsmaate for fremstilling av nye s-adenosylmethionin-derivater.
NO911118D0 (no) Fremgangsmaate for fremstilling av nye 8-sulfamylmethylen-2-amino-tetraliner.
NO901067L (no) Fremgangsmaate for fremstilling av tiofener.
NO872393D0 (no) Fremgangsmaate for fremstilling av nye aralkylimidazolderivater.
NO904060L (no) Fremgangsmaate for fremstilling av substituerte dibenzofuraner.
NO900969L (no) Fremgangsmaate for fremstilling av n-allymetatrifluormetylanilin.
NO871721L (no) Fremgangsmaate for fremstilling av nye ergolenderivater.
NO900935D0 (no) Fremgangsmaate for fremstilling av nye piperidinderivater.
NO902293L (no) Fremgangsmaate for fremstilling av nye tiazepinderivater.
NO901401D0 (no) Fremgangsmaate for fremstilling av nye 1-difenylmethylpiperidinderivater.
NO893006D0 (no) Fremgangsmaate for fremstilling av nye allylaminoetylazoler
NO902967D0 (no) Fremgangsmaate til fremstilling av nye sulfamoyltiofener.
NO904070D0 (no) Fremgangsmaate for fremstilling av alkanfenoner.
NO882564D0 (no) Fremgangsmaate for fremstilling av nye aminoacylater av glycerolacetal.
NO882172D0 (no) Fremgangsmaate ved fremstilling av nye indansulfonamider.